{"id":"https://openalex.org/W2008833332","doi":"https://doi.org/10.1254/jjp.35.37","title":"Time-Dependent Inhibition of Prostaglandins Synthesis by Nonsteroidal Antiinflammatory Drugs; Time-Dependent Alteration of Inhibitory Effect and Characteristics of its Active Site","display_name":"Time-Dependent Inhibition of Prostaglandins Synthesis by Nonsteroidal Antiinflammatory Drugs; Time-Dependent Alteration of Inhibitory Effect and Characteristics of its Active Site","publication_year":1984,"publication_date":"1984-01-01","ids":{"openalex":"https://openalex.org/W2008833332","doi":"https://doi.org/10.1254/jjp.35.37","mag":"2008833332","pmid":"https://pubmed.ncbi.nlm.nih.gov/6433094"},"language":"en","primary_location":{"id":"doi:10.1254/jjp.35.37","doi":"https://doi.org/10.1254/jjp.35.37","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.35.37","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1254/jjp.35.37","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088760818","display_name":"Makoto Muramatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto MURAMATSU","raw_affiliation_strings":["Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","Taisho Pharmaceutical Co.Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Taisho Pharmaceutical Co.Ltd","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078533281","display_name":"Makoto Tanaka","orcid":"https://orcid.org/0000-0001-5545-3443","observed_orcids":["https://orcid.org/0000-0001-5545-3443"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto TANAKA","raw_affiliation_strings":["Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","Taisho Pharmaceutical Co.Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Taisho Pharmaceutical Co.Ltd","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103781450","display_name":"Atsuko Fujita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuko FUJITA","raw_affiliation_strings":["Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","Taisho Pharmaceutical Co.Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Taisho Pharmaceutical Co.Ltd","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112817015","display_name":"Susumu Otomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu OTOMO","raw_affiliation_strings":["Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","Taisho Pharmaceutical Co.Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Taisho Pharmaceutical Co.Ltd","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111532471","display_name":"Hironaka Aihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hironaka AIHARA","raw_affiliation_strings":["Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","Taisho Pharmaceutical Co.Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taisho Pharmaceutical Co., Ltd, Research Center, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Taisho Pharmaceutical Co.Ltd","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":null,"apc_paid":null,"fwci":0.3847,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.53718674,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"35","issue":"1","first_page":"37","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9490000009536743},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibition","display_name":"cyclooxygenase inhibition","score":0.9470000267028809},{"id":"https://openalex.org/keywords/time-dependent-inhibition","display_name":"time-dependent inhibition","score":0.9319999814033508},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.800000011920929},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.9990000128746033},{"id":"https://openalex.org/keywords/flurbiprofen","display_name":"flurbiprofen","score":1.0},{"id":"https://openalex.org/keywords/salicylic-acid","display_name":"salicylic acid","score":0.925000011920929},{"id":"https://openalex.org/keywords/prostaglandin-synthesis","display_name":"prostaglandin synthesis","score":0.847000002861023},{"id":"https://openalex.org/keywords/enzyme-active-site","display_name":"enzyme active site","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.8800606727600098},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.8264998197555542},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6003594994544983},{"id":"https://openalex.org/C3019987054","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose dependence","level":2,"score":0.5959004759788513},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5735974311828613},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.4107041358947754},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21855664253234863},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19501736760139465},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17565041780471802},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08221682906150818}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005480","descriptor_name":"Flurbiprofen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011448","descriptor_name":"Prostaglandin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D012459","descriptor_name":"Salicylates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020156","descriptor_name":"Salicylic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1254/jjp.35.37","doi":"https://doi.org/10.1254/jjp.35.37","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.35.37","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:6433094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6433094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1254/jjp.35.37","doi":"https://doi.org/10.1254/jjp.35.37","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.35.37","pdf_url":null,"source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1536157072","https://openalex.org/W1567233573","https://openalex.org/W1775749144","https://openalex.org/W1983759759","https://openalex.org/W1986903703","https://openalex.org/W1999516340","https://openalex.org/W2008574207","https://openalex.org/W2020106476","https://openalex.org/W2024715019","https://openalex.org/W2027233484","https://openalex.org/W2081278239","https://openalex.org/W2085965632","https://openalex.org/W2134397585","https://openalex.org/W2401692015"],"related_works":["https://openalex.org/W3099675654","https://openalex.org/W2024175","https://openalex.org/W2025945817","https://openalex.org/W1921815852","https://openalex.org/W2090359132","https://openalex.org/W1608437430","https://openalex.org/W2081278239","https://openalex.org/W1976365391","https://openalex.org/W4221063952","https://openalex.org/W325404784"],"abstract_inverted_index":{"The":[0,26,53],"characteristics":[1],"of":[2,5,29,33,97,113,116,130,186,197,201,211,213,221,233,246],"the":[3,30,76,79,103,106,110,114,117,128,131,134,143,150,183,195,198,204,209,214,218,222,226,231,234,240,243,247],"time-dependency":[4],"nonsteroidal":[6],"antiinflammatory":[7],"drugs":[8,42,99],"(NSAIDs)":[9],"and":[10,58,64,189,225],"their":[11],"active":[12],"sites":[13],"in":[14,78,94,105,142,173,175,237],"inhibiting":[15,70,95],"cyclooxygenase":[16,69,171,235],"activity":[17,96,172],"were":[18,36,48,60,86,145,159],"investigated":[19],"using":[20],"bovine":[21],"seminal":[22],"vesicle":[23],"microsomal":[24],"fraction.":[25],"Hill's":[27,45,83,111,151,219],"coefficients":[28,46,84],"inhibition":[31,107,199,223],"curve":[32,115,132,144,200],"most":[34],"NSAIDs":[35,77,118,215],"approximately":[37,61],"1.0,":[38],"except":[39],"for":[40,55,230,242],"some":[41],"which":[43,81,164],"had":[44,82],"that":[47,85,182,208],"obviously":[49],"more":[50,88,122],"than":[51,89,123],"1.0.":[52,90,124,155],"values":[54],"indomethacin,":[56],"diclofenac":[57],"flurbiprofen":[59],"1.5,":[62],"1.7":[63],"2.0,":[65],"respectively.":[66],"A":[67,91],"time-dependent":[68,92,157,188],"effect":[71,169],"was":[72,100,136],"observed":[73,101,138],"only":[74],"with":[75],"group":[80],"significantly":[87],"increase":[93],"these":[98],"by":[102,161,194],"change":[104],"curve.":[108],"Time-dependently,":[109],"coefficient":[112,152,220],"approached":[119],"1.0":[120],"from":[121],"With":[125],"this":[126],"change,":[127],"shift":[129],"to":[133,154,239],"left":[135],"also":[137],"time-dependently.":[139],"These":[140,156,179],"changes":[141],"no":[146],"longer":[147],"seen":[148],"when":[149],"dropped":[153],"effects":[158],"protected":[160],"salicylic":[162],"acid,":[163],"did":[165],"not":[166],"have":[167],"any":[168],"on":[170,217],"vitro,":[174],"a":[176],"dose-dependent":[177],"manner.":[178],"results":[180,206],"suggested":[181],"two":[184],"classes":[185],"NSAIDs,":[187],"non-time-dependent,":[190],"are":[191],"clearly":[192],"differentiated":[193],"slope":[196],"NSAIDs.":[202],"Furthermore,":[203],"present":[205],"indicate":[207],"degree":[210],"time-dependence":[212],"depends":[216],"curve,":[224],"value":[227],"is":[228],"important":[229],"potency":[232],"inhibition,":[236],"addition":[238],"affinity":[241],"catalytic":[244],"site":[245],"enzyme.":[248]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}